These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 26233840)
1. Guidelines and strategy of the International Conference of Harmonization (ICH) and its member states to overcome existing impurity control problems for antibiotics in China. Jiang Y; Xia JP; Yang JH; Zhang ZF; Hu CQ; Zhang ZR Chin J Nat Med; 2015 Jul; 13(7):498-506. PubMed ID: 26233840 [TBL] [Abstract][Full Text] [Related]
2. Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect Analysis. Matsuhama M; Saito R; Miyazaki S Chem Pharm Bull (Tokyo); 2020; 68(11):1034-1048. PubMed ID: 33132370 [TBL] [Abstract][Full Text] [Related]
3. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>. Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566 [TBL] [Abstract][Full Text] [Related]
4. Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference. Yu LX; Baker J; Berlam SC; Boam A; Brandreth EJ; Buhse L; Cosgrove T; Doleski D; Ensor L; Famulare J; Ganapathy M; Grampp G; Hussong D; Iser R; Johnston G; Kesisoglou F; Khan M; Kozlowski S; Lacana E; Lee SL; Miller S; Miksinski SP; Moore CM; Mullin T; Raju GK; Raw A; Rosencrance S; Rosolowsky M; Stinavage P; Thomas H; Wesdyk R; Windisch J; Vaithiyalingam S AAPS J; 2015 Jul; 17(4):1011-8. PubMed ID: 25840884 [TBL] [Abstract][Full Text] [Related]
5. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Particulate Contamination: Subvisible Particles General Chapter; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2009 Jan; 74(6):909-10. PubMed ID: 20336864 [TBL] [Abstract][Full Text] [Related]
6. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
7. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2009 Apr; 74(66):15992-3. PubMed ID: 19507323 [TBL] [Abstract][Full Text] [Related]
8. [ICH4 and pharmacopoeias: similarities and differences]. Artiges A Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473 [TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 8 on Sterility Test General Chapter; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2009 Dec; 74(244):68068-9. PubMed ID: 20336863 [TBL] [Abstract][Full Text] [Related]
10. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the European Pharmacopoeia method for control of residual solvents in some antibiotics. Sitaramaraju Y; Riadi A; D'Autry W; Wolfs K; Hoogmartens J; Van Schepdael A; Adams E J Pharm Biomed Anal; 2008 Sep; 48(1):113-9. PubMed ID: 18584990 [TBL] [Abstract][Full Text] [Related]
12. Industry perspectives on ICH guidelines. Rockhold FW Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111 [TBL] [Abstract][Full Text] [Related]
13. Design and international harmonization of pharmacopoeial standards. Calam DH J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Extractable Elements from Elastomers. Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347 [TBL] [Abstract][Full Text] [Related]
15. [Objectives and organization of the International Conference on Harmonization]. Juillet Y Ann Pharm Fr; 1999 Mar; 57(2):137-42. PubMed ID: 10365469 [TBL] [Abstract][Full Text] [Related]
17. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
18. Regulatory advice and drug development--a case study in negotiating with regulators. Seldrup J Stat Med; 2011 Jun; 30(13):1628-35. PubMed ID: 21365671 [TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2009 Jan; 74(6):908-9. PubMed ID: 20333832 [TBL] [Abstract][Full Text] [Related]
20. Harmonization, regulation, and trade: where do we go from here? Horton LR PDA J Pharm Sci Technol; 1996; 50(1):61-5. PubMed ID: 8846062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]